"delay in the release past April should not indicate any problems"
The company has stated that clinical data would be available this month. That was probably a mistake since they don't have any control over how long it will really take to compile the data. So a delay does not indicate any problems.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.